Daniel P. Petrylak, MD
Herbert Irving Comprehensive Cancer Center
6
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Primo N. Lara, MD
University of California, Davis
Shared therapeutic areas:
Worked with same sponsors:
Eric J. Small, MD
University of California, San Francisco
Shared therapeutic areas:
Worked with same sponsors:
Rahul Aggarwal, MD
University of California, San Francisco
Shared therapeutic areas:
Worked with same sponsors:
Chi Fai Ng, MD
Chinese University of Hong Kong
Shared therapeutic areas:
Patrick A. Burch, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
George Wilding, MD
University of Wisconsin, Madison
Shared therapeutic areas:
Worked with same sponsors:
Kevin Volpp, MD, PhD
University of Pennsylvania
Shared therapeutic areas:
Lung-Ji Chang, PhD
Shenzhen Geno-Immune Medical Institute
Shared therapeutic areas:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Neha sharma, PhD
Warwick Research Services
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium
All 6 trials loaded